Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

NCT01490853 · clinicaltrials.gov ↗

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Interpheron alpha

Sponsor

Università degli Studi di Brescia